362 - Combining 47 clinical and neuroimaging variables to predict adverse 18-22-month outcomes for Hypoxic Ischemic Encephalopathy in Neonatal Research Network trials

Yangming Ou, Boston Children's Hospital, Boston, MA, United States; Ankush Kesri, Boston Children's Hospital, Boston, MA, United States; rina bao, Boston Children's Hospital, Boston, MA, United States; Chuan-Heng Hsiao, Boston Children's Hospital, Brookline, MA, United States; Rutvi Vyas, Boston Children's Hospital, Boston, MA, United States; Mohammad Arafat Hussain, Boston Children's Hospital/Harvard Medical School, Quincy, MA, United States; Scott A.. McDonald, RTI International, Raleigh, NC, United States; Jeanette O. Auman, RTI, Durham, NC, United States; Anna N.. Foster, Boston Children's Hospital, Boston, MA, United States; Janet Soul, Boston Children's Hospital, Boston, MA, United States; Erfan Darzidehkalani, Boston Childrens hospital, Boston, MA, United States; Matheus Dorigatti Soldatelli, Boston Children's Hospital, Boston, MA, United States; Seetha Shankaran, The University of Texas at Austin, Ann Arbor, MI, United States; Abbot Laptook, Women & Infants Hospital of Rhode Island, Providence, RI, United States; Michael Cotten, Duke university, Durham, NC, United States; Patricia Ellen. Grant, Boston Children's Hospital, Boston, MA, United States